Fusobacterium nucleatum exacerbates chronic obstructive pulmonary disease in elastase-induced emphysematous mice

FEBS Open Bio. 2022 Mar;12(3):638-648. doi: 10.1002/2211-5463.13369. Epub 2022 Jan 30.

Abstract

Exacerbation of chronic obstructive pulmonary disease (COPD) is associated with disease progression and increased mortality. Periodontal disease is a risk factor for exacerbation of COPD, but little is known about the role of periodontopathic bacteria in this process. Here, we investigated the effects of intratracheal administration of Fusobacterium nucleatum, a periodontopathic bacteria species, on COPD exacerbation in elastase-induced emphysematous mice. The administration of F. nucleatum to elastase-treated mice enhanced inflammatory responses, production of alveolar wall destruction factors, progression of emphysema, and recruitment of mucin, all of which are symptoms observed in patients with COPD exacerbation. Hence, we propose that F. nucleatum may play a role in exacerbation of COPD.

Keywords: Fusobacterium nucleatum; COPD exacerbations; chronic obstructive pulmonary disease; emphysema; periodontal disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Emphysema* / complications
  • Fusobacterium nucleatum
  • Humans
  • Mice
  • Pancreatic Elastase / adverse effects
  • Pulmonary Disease, Chronic Obstructive* / chemically induced
  • Pulmonary Emphysema* / chemically induced
  • Pulmonary Emphysema* / complications

Substances

  • Pancreatic Elastase